Global Transthyretin Market By Product Type (AG-10, ALN-TTRsc02) And By End-Users/Application (Familial Amyloid Neuropathies, Alzheimer's Disease) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-985514
  • April 2021
  • Pharmaceuticals
  • 119 Pages

Report Preview

The global Transthyretin market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Transthyretin market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Transthyretin market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Transthyretin market.

Apart from this, the market research report also covers drivers and restraints for the global Transthyretin market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Transthyretin market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Transthyretin market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

XYZ Market Strategic Analysis:
In 2019, the global XYZ market was valued at US$ xx Mn, and it is expected to reach at US$ xx Mn at a CAGR of xx% during 2020-2028.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Transthyretin market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty. 
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type AG-10, ALN-TTRsc02, CRX-1008, EDE-1307, Inotersen Sodium, Others
Applications Familial Amyloid Neuropathies, Alzheimer\'s Disease, Cardomyopathy, Neuropathy, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Pfizer Inc, Prothena Corp Plc, Regeneron Pharmaceuticals Inc

Transthyretin Market Segment Analysis:
The Transthyretin market research report segments the market based on its types, applications and end-use industry. All the segments of the market are analyzed and evaluated based on current and future trends of the market. The data for the segments and its categories is provided from 2018 to 2028. 

Transthyretin Market, by Type: AG-10, ALN-TTRsc02, CRX-1008, EDE-1307, Inotersen Sodium, Others

Transthyretin Market, by Application: Familial Amyloid Neuropathies, Alzheimer\'s Disease, Cardomyopathy, Neuropathy, Others

Major Key Players for Global Transthyretin Market:
The Transthyretin market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Pfizer Inc, Prothena Corp Plc, Regeneron Pharmaceuticals Inc

Geographic Coverage for Transthyretin Market:
The market research report on global Transthyretin market offers complete analysis across various regions across the world. The Transthyretin market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Transthyretin market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Transthyretin Market Value and Forecast
  • US
  • Canada

Europe Transthyretin Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe

Asia Pacific Transthyretin Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific

Latin America Transthyretin Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America

Middle East and Africa Transthyretin Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Key highlights of the Transthyretin market report:
  • The report provides key trends of the global Transthyretin market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Transthyretin industry
  • The report covers all the recent developments of the Transthyretin market and helps to provide current industry updates
  • The report covers a detailed look over the global Transthyretin Industry and provides with significant actionable insights
  • The Transthyretin market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Transthyretin market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Transthyretin market
  • Comprehensive analysis of the Transthyretin market segments based on its types, applications and end-use industry

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Transthyretin market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Transthyretin market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Transthyretin market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Transthyretin market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Transthyretin market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Transthyretin Market Snapshot
          2.1.1. Global Transthyretin Market By Type,2019
               2.1.1.1.AG-10
               2.1.1.2.ALN-TTRsc02
               2.1.1.3.CRX-1008
               2.1.1.4.EDE-1307
               2.1.1.5.Inotersen Sodium
               2.1.1.6.Others
          2.1.2. Global Transthyretin Market By Application,2019
               2.1.2.1.Familial Amyloid Neuropathies
               2.1.2.2.Alzheimer's Disease
               2.1.2.3.Cardomyopathy
               2.1.2.4.Neuropathy
               2.1.2.5.Others
          2.1.3. Global Transthyretin Market By End-use,2019
          2.1.4. Global Transthyretin Market By Geography,2019

3. Global Transthyretin Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Transthyretin Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Transthyretin Market Size (US$), By Type, 2018 – 2028

5. Global Transthyretin Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Transthyretin Market Size (US$), By Application, 2018 – 2028

6. Global Transthyretin Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Transthyretin Market Size (US$), By End-use, 2018 – 2028

7. Global Transthyretin Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Transthyretin Market Analysis, 2018 – 2028 
          7.2.1. North America Transthyretin Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Transthyretin Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Transthyretin Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Transthyretin Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Transthyretin Market Analysis, 2018 – 2028 
          7.3.1.  Europe Transthyretin Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Transthyretin Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Transthyretin Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Transthyretin Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Transthyretin Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Transthyretin Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Transthyretin Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Transthyretin Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Transthyretin Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Transthyretin Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Transthyretin Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Transthyretin Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Transthyretin Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Transthyretin Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Transthyretin Market Analysis, 2018 – 2028 
          7.6.1.  MEA Transthyretin Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Transthyretin Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Transthyretin Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Transthyretin Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Transthyretin Providers
        8.4.1 Alnylam Pharmaceuticals Inc
                8.1.1 Business Description
                8.1.2 Alnylam Pharmaceuticals Inc Geographic Operations
                8.1.3 Alnylam Pharmaceuticals Inc Financial Information
                8.1.4 Alnylam Pharmaceuticals Inc Product Positions/Portfolio
                8.1.5 Alnylam Pharmaceuticals Inc Key Developments
        8.4.2 Arcturus Therapeutics Inc
                8.2.1 Business Description
                8.2.2 Arcturus Therapeutics Inc Geographic Operations
                8.2.3 Arcturus Therapeutics Inc Financial Information
                8.2.4 Arcturus Therapeutics Inc Product Positions/Portfolio
                8.2.5 Arcturus Therapeutics Inc Key Developments
        8.4.3 Ionis Pharmaceuticals Inc
                8.3.1 Business Description
                8.3.2 Ionis Pharmaceuticals Inc Geographic Operations
                8.3.3 Ionis Pharmaceuticals Inc Financial Information
                8.3.4 Ionis Pharmaceuticals Inc Product Positions/Portfolio
                8.3.5 Ionis Pharmaceuticals Inc Key Developments
        8.4.4 Neurimmune Holding AG
                8.4.1 Business Description
                8.4.2 Neurimmune Holding AG Geographic Operations
                8.4.3 Neurimmune Holding AG Financial Information
                8.4.4 Neurimmune Holding AG Product Positions/Portfolio
                8.4.5 Neurimmune Holding AG Key Developments
        8.4.5 Pfizer Inc
                8.5.1 Business Description
                8.5.2 Pfizer Inc Geographic Operations
                8.5.3 Pfizer Inc Financial Information
                8.5.4 Pfizer Inc Product Positions/Portfolio
                8.5.5 Pfizer Inc Key Developments
        8.4.6 Prothena Corp Plc
                8.6.1 Business Description
                8.6.2 Prothena Corp Plc Geographic Operations
                8.6.3 Prothena Corp Plc Financial Information
                8.6.4 Prothena Corp Plc Product Positions/Portfolio
                8.6.5 Prothena Corp Plc Key Developments
        8.4.7 Regeneron Pharmaceuticals Inc
                8.7.1 Business Description
                8.7.2 Regeneron Pharmaceuticals Inc Geographic Operations
                8.7.3 Regeneron Pharmaceuticals Inc Financial Information
                8.7.4 Regeneron Pharmaceuticals Inc Product Positions/Portfolio
                8.7.5 Regeneron Pharmaceuticals Inc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Transthyretin Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Transthyretin Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Transthyretin Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Transthyretin Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Transthyretin Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Transthyretin Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Transthyretin Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Transthyretin Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Transthyretin Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Transthyretin Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Transthyretin Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Transthyretin Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Transthyretin Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Transthyretin Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Transthyretin Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Transthyretin Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Transthyretin: Market Segmentation 
FIG. 2 Global Transthyretin Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Transthyretin Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Transthyretin Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Transthyretin Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Transthyretin Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Transthyretin Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Transthyretin Providers, 2019
FIG. 11 Global Transthyretin Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Transthyretin Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Transthyretin Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Transthyretin Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Transthyretin Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Transthyretin Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Transthyretin Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Transthyretin Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Transthyretin market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Transthyretin Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Transthyretin Market Value, By Segment1, 2018 – 2028
TABLE  North America Transthyretin Market Value, By Segment2, 2018 – 2028
TABLE  North America Transthyretin Market Value, By Country, 2018 – 2028
TABLE  Europe Transthyretin Market Value, By Segment1, 2018 – 2028
TABLE  Europe Transthyretin Market Value, By Segment2, 2018 – 2028
TABLE  Europe Transthyretin Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Transthyretin Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Transthyretin Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Transthyretin Market Value, By Country, 2018 – 2028
TABLE  Latin America Transthyretin Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Transthyretin Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Transthyretin Market Value, By Country, 2018 – 2028
TABLE  MEA Transthyretin Market Value, By Segment1, 2018 – 2028
TABLE  MEA Transthyretin Market Value, By Segment2, 2018 – 2028
TABLE  MEA Transthyretin Market Value, By Country, 2018 – 2028
TABLE  Alnylam Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Arcturus Therapeutics Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ionis Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Neurimmune Holding AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Prothena Corp Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Regeneron Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Transthyretin Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Transthyretin Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Transthyretin Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Transthyretin Market, By Geography, 2019 (US$ Mn)
FIG.  Global Transthyretin Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Transthyretin Providers, 2016
FIG.  Global Transthyretin Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global AG-10 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global ALN-TTRsc02 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global CRX-1008 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global EDE-1307 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Inotersen Sodium Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Transthyretin Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Familial Amyloid Neuropathies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Alzheimer's Disease Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cardomyopathy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Neuropathy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Transthyretin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Transthyretin Market Value, 2018 – 2028, (US$ Mn)